The effect of allopurinol on renal outcomes in patients with diabetic kidney disease: A systematic review and meta-analysis
Background: Hyperuricemia is an independent risk factor for diabetic kidney disease (DKD) progression. Previous animal and cohort studies have reported that allopurinol administration could be of therapeutic benefit in diabetic subjects. However, there has been controversy regarding the effects of a...
Saved in:
Main Authors: | Binbin Wu (Author), Lili Chen (Author), Yuankai Xu (Author), Qingqing Duan (Author), Zhibo Zheng (Author), Zhigui Zheng (Author), Dongyuan He (Author) |
---|---|
Format: | Book |
Published: |
Karger Publishers,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of allopurinol on the treatment of chronic kidney disease: a systematic review and meta-analysis
by: Aiyoub Pezeshgi, et al.
Published: (2023) -
The effect of allopurinol on the progression of chronic kidney disease
by: Aygul Ozdemir, et al.
Published: (2017) -
Biomarkers of iron status in allopurinol-treated renal stone patients
by: Adnan A. Zainal, et al.
Published: (2021) -
Allopurinol Use and the Risk of Type 2 Diabetes Mellitus: A Meta-Analysis of Cohort Studies
by: Shih-Wei Lai MD, et al.
Published: (2022) -
Cardiovascular safety of febuxostat and allopurinol in patients with gout: A meta-analysis
by: Xudong Guan, et al.
Published: (2022)